ATE197669T1 - Verwendung von beta-naphthochinonderivaten zur hemmung von blutplättchen-aggregation - Google Patents
Verwendung von beta-naphthochinonderivaten zur hemmung von blutplättchen-aggregationInfo
- Publication number
- ATE197669T1 ATE197669T1 AT94401461T AT94401461T ATE197669T1 AT E197669 T1 ATE197669 T1 AT E197669T1 AT 94401461 T AT94401461 T AT 94401461T AT 94401461 T AT94401461 T AT 94401461T AT E197669 T1 ATE197669 T1 AT E197669T1
- Authority
- AT
- Austria
- Prior art keywords
- beta
- derivatives
- aggregation
- naphthochinone
- platele
- Prior art date
Links
- 230000002776 aggregation Effects 0.000 title 1
- 238000004220 aggregation Methods 0.000 title 1
- 125000000614 1,2-naphthoquinonyl group Chemical class C1(C(C(=CC2=CC=CC=C12)*)=O)=O 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 229940126601 medicinal product Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
- A61K31/175—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine having the group, >N—C(O)—N=N— or, e.g. carbonohydrazides, carbazones, semicarbazides, semicarbazones; Thioanalogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9308112A FR2707495B1 (fr) | 1993-07-02 | 1993-07-02 | Nouvelle utilisation de dérivés de la béta-naphtoquinone ainsi que de leurs sels. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE197669T1 true ATE197669T1 (de) | 2000-12-15 |
Family
ID=9448828
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT94401461T ATE197669T1 (de) | 1993-07-02 | 1994-06-28 | Verwendung von beta-naphthochinonderivaten zur hemmung von blutplättchen-aggregation |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5523322A (de) |
| EP (1) | EP0631777B1 (de) |
| JP (1) | JP3993646B2 (de) |
| AT (1) | ATE197669T1 (de) |
| CA (1) | CA2127215C (de) |
| DE (1) | DE69426317T2 (de) |
| DK (1) | DK0631777T3 (de) |
| ES (1) | ES2154286T3 (de) |
| FR (1) | FR2707495B1 (de) |
| GR (1) | GR3035058T3 (de) |
| HU (1) | HU214058B (de) |
| PT (1) | PT631777E (de) |
| RU (1) | RU2122853C1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE1011151A3 (fr) * | 1997-05-13 | 1999-05-04 | Jose Remacle | Utilisation d'une composition pharmaceutique dans le traitement et/ou la prevention de l'ischemie. |
| FR2796552A1 (fr) * | 1999-07-21 | 2001-01-26 | Centre Nat Rech Scient | Nouvelle utilisation de derives de la beta-naphtoquinone et de leurs sels pour la fabrication de medicaments exercant un effet inhibiteur sur la liberation de glutamate dans le cerveau |
| RU2410104C1 (ru) * | 2009-07-10 | 2011-01-27 | Учреждение Российской академии медицинских наук Научный центр неврологии РАМН | СПОСОБ СНИЖЕНИЯ АГРЕГАЦИОННОЙ АКТИВНОСТИ ТРОМБОЦИТОВ in vitro |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR924M (de) * | 1959-09-26 | 1961-11-13 | ||
| GB8310140D0 (en) * | 1983-04-14 | 1983-05-18 | Wellcome Found | Antiprotozoal agents |
-
1993
- 1993-07-02 FR FR9308112A patent/FR2707495B1/fr not_active Expired - Fee Related
-
1994
- 1994-06-28 ES ES94401461T patent/ES2154286T3/es not_active Expired - Lifetime
- 1994-06-28 DK DK94401461T patent/DK0631777T3/da active
- 1994-06-28 AT AT94401461T patent/ATE197669T1/de active
- 1994-06-28 EP EP94401461A patent/EP0631777B1/de not_active Expired - Lifetime
- 1994-06-28 DE DE69426317T patent/DE69426317T2/de not_active Expired - Lifetime
- 1994-06-28 PT PT94401461T patent/PT631777E/pt unknown
- 1994-06-30 CA CA002127215A patent/CA2127215C/fr not_active Expired - Fee Related
- 1994-06-30 US US08/269,649 patent/US5523322A/en not_active Expired - Lifetime
- 1994-07-01 JP JP17158694A patent/JP3993646B2/ja not_active Expired - Fee Related
- 1994-07-01 RU RU94022757/14A patent/RU2122853C1/ru not_active IP Right Cessation
- 1994-07-01 HU HU9401978A patent/HU214058B/hu not_active IP Right Cessation
-
2000
- 2000-12-13 GR GR20000402746T patent/GR3035058T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2122853C1 (ru) | 1998-12-10 |
| HU214058B (en) | 1997-12-29 |
| US5523322A (en) | 1996-06-04 |
| EP0631777A1 (de) | 1995-01-04 |
| FR2707495A1 (fr) | 1995-01-20 |
| HU9401978D0 (en) | 1994-09-28 |
| DE69426317D1 (de) | 2000-12-28 |
| PT631777E (pt) | 2001-05-31 |
| CA2127215C (fr) | 2004-10-26 |
| FR2707495B1 (fr) | 1995-09-01 |
| DK0631777T3 (da) | 2001-03-05 |
| CA2127215A1 (fr) | 1995-01-03 |
| GR3035058T3 (en) | 2001-03-30 |
| JPH07145128A (ja) | 1995-06-06 |
| HUT70508A (en) | 1995-10-30 |
| EP0631777B1 (de) | 2000-11-22 |
| RU94022757A (ru) | 1996-09-27 |
| JP3993646B2 (ja) | 2007-10-17 |
| DE69426317T2 (de) | 2001-05-03 |
| ES2154286T3 (es) | 2001-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0530505T3 (da) | Hydantoinderivater | |
| ATE175669T1 (de) | Sulfonylaminopyrimidine, ihre herstellung und verwendung als heilmittel | |
| ATE415394T1 (de) | Zwischeprodukte zur herstellung von retroviralen protease-hemmern | |
| AU1611192A (en) | Fibrinogen receptor antagonists | |
| NO180166C (no) | Pyrrolidin- og tiazolidinderivater samt medikamenter inneholdende forbindelsene | |
| DK0505868T3 (da) | N-acyl-alpha-aminosyrederivater | |
| CO4290432A1 (es) | Nuevos derivados de pirazinacarboxamida, su preparacion y su utilizacion en medicamentos. | |
| EP0614913A3 (de) | Dynorphin Derivate. | |
| EP0712844A4 (de) | Neue kondensierte carbonsäureverbindung oder ihr salz und ihre medizinische verwendung | |
| ATE174322T1 (de) | Verwendung aromatischer carbonsäurederivate zur herstellung von pharmazeutischen präparaten | |
| ATE191849T1 (de) | Verwendung von (s)-(-)-alpha-ethyl-2-oxo-1- pyrrolidinacetamid zur herstellung eines medikaments zur behandlung von angst | |
| ATE132861T1 (de) | Derivate von hexahydroazepine, verfahren zu ihrer herstellung und diese enthaltende arzneimittel | |
| DE3861380D1 (de) | Fluessigkristallverbindung vom tolan-typ. | |
| ATE57095T1 (de) | Verwendung von hydroxyindolderivaten zur herstellung eines arzneimittels zur senkung des blutdrucks. | |
| ATE197669T1 (de) | Verwendung von beta-naphthochinonderivaten zur hemmung von blutplättchen-aggregation | |
| DE69426316D1 (de) | Verwendung von Beta-Naphthochinonderivaten zur Beschleunigung der Proliferation der Endothelzellen und Inhibierung der NO-Synthasen | |
| DE68905657D1 (de) | Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen. | |
| DE69304409D1 (de) | Neues Hexapeptid | |
| ES8605247A1 (es) | Procedimiento para la obtencion de arisulfonilguanidinas sustituidas | |
| DK626889D0 (da) | Indanderivater, deres fremstilling samt laegemidler med indhold deraf | |
| YU47723B (sh) | Postupak za dobivanje derivata 2-imino-3-heterocikloalkilbenzotiazolina | |
| DE3762854D1 (de) | Pharmazeutische zusammensetzungen mit inhalt von 5-phenyl-1,3-dioxoalkenylverbindungen. | |
| FR2627487B1 (fr) | Nouveau derive de l'acide valproique, procede de preparation de ce compose ainsi que medicament antiepileptique le contenant | |
| DE69402241D1 (de) | Verwendung von 2-Acetylpyridine zur Herstellung eines Arzneimittles zur Unterdrückung des Rauchens | |
| ATE74354T1 (de) | N-karbethoxy-4-thiazolin-karbonsaeure, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| EEIH | Change in the person of patent owner |